RPG Life Sciences accepts Deepak Shukla's resignation as API head
RPG Life Sciences Limited announced the resignation of Deepak Shukla as Chief Executive - API Business, effective August 14, 2026. Shukla will assume the role of Chief Executive Officer at RPG Active Pharma Limited, a wholly-owned subsidiary, starting August 15, 2026. The transition was disclosed under Regulation 30 of SEBI Listing Regulations, marking an internal leadership shift within the group.
*this image is generated using AI for illustrative purposes only.
RPG Life Sciences has accepted the resignation of Deepak Shukla as Chief Executive - API Business, effective close of business hours on August 14, 2026. The leadership change coincides with Shukla’s appointment as Chief Executive Officer of RPG Active Pharma Limited, a wholly-owned subsidiary of the parent company, which takes effect on August 15, 2026.
The company disclosed the transition in a filing to the National Stock Exchange of India Limited and BSE Limited on August 15, 2026. The move represents an internal restructuring within the RPG Life Sciences group rather than a departure from the corporate ecosystem.
Regulatory Disclosure Details
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also referenced SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, in its filing.
| Particulars | Details |
|---|---|
| Resigning Executive | Deepak Shukla |
| Former Role | Chief Executive - API Business |
| Effective Date | Close of business hours on August 14, 2026 |
| New Role | Chief Executive Officer |
| New Entity | RPG Active Pharma Limited (Wholly-owned subsidiary) |
| New Role Start Date | August 15, 2026 |
Shukla submitted his resignation letter to the Managing Director of RPG Life Sciences Limited on August 14, 2026, citing his new appointment as the reason for ceasing to be a Senior Management Personnel of the parent company. Rajesh Shirambekar, Head – Legal & Company Secretary, signed the disclosure letter.
Historical Stock Returns for RPG Life Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.70% | +3.47% | -1.44% | +40.90% | +21.95% | +417.20% |
How will the separation of RPG Active Pharma Limited's leadership from the parent company impact the strategic autonomy and operational focus of the API business unit?
What criteria or timeline has RPG Life Sciences established for appointing a successor to Deepak Shukla as Chief Executive - API Business?
Could this internal restructuring signal a potential future spin-off, demerger, or independent listing for RPG Active Pharma Limited?
17
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
